Edition:
India

Eurofins Scientific SE (EUFI.PA)

EUFI.PA on Paris Stock Exchange

335.00EUR
10:05pm IST
Change (% chg)

€11.60 (+3.59%)
Prev Close
€323.40
Open
€330.00
Day's High
€351.20
Day's Low
€327.20
Volume
57,139
Avg. Vol
33,848
52-wk High
€545.50
52-wk Low
€322.80

Latest Key Developments (Source: Significant Developments)

Eurofins Scientific Further Redeems Its EUR 300M November 2018 Eurobond And Extends Its Organic Growth Objectives Beyond 2020
Monday, 26 Nov 2018 

Nov 26 (Reuters) - Eurofins Scientific SE ::EUROFINS FURTHER REDUCES ITS FINANCING COSTS AFTER REDEEMING ITS EUR 300M NOVEMBER 2018 EUROBOND AND EXTENDS ITS ORGANIC GROWTH OBJECTIVES BEYOND 2020.CONFIRMS ITS 2018 OBJECTIVES.CONFIRM ITS 2018 OBJECTIVES.BELIEVES THAT SETTING A SECULAR ANNUAL ORGANIC GROWTH TARGET OF 5% BEYOND 2020 IS AN ACHIEVABLE OBJECTIVE..EXPECTS TO SEE BENEFITS ON ITS ORGANIC GROWTH AND PROFITABILITY OF ITS EXCEPTIONAL 2015-2020 INFRASTRUCTURE AND IT SOLUTIONS INVESTMENT PROGRAMME.IN JANUARY 2020, EUROFINS’ EXPENSIVE HYBRID (EUR 300M, 7% FIXED COUPON) WILL BECOME CALLABLE AND THIS SHOULD ALSO PROVIDE CO WITH ANOTHER OPPORTUNITY TO FREE CASH FLOW FOR ITS INVESTMENTS AND ITS SHAREHOLDERS.  Full Article

Eurofins Acquires Laboratoire Dermscan
Monday, 29 Oct 2018 

Oct 29 (Reuters) - EUROFINS SCIENTIFIC SE ::EUROFINS IS REINFORCING ITS GLOBAL LEADERSHIP IN COSMETIC & PERSONAL CARE PRODUCTS TESTING WITH THE ACQUISITION OF DERMSCAN IN FRANCE.EUROFINS IS REINFORCING ITS GLOBAL LEADERSHIP IN COSMETIC & PERSONAL CARE PRODUCTS TESTING WITH THE ACQUISITION OF DERMSCAN IN FRANCE.SUCCESSFULLY CLOSED ACQUISITION OF LABORATOIRE DERMSCAN SAS.  Full Article

Eurofins Acquires Clinical Research Laboratories In North America
Tuesday, 4 Sep 2018 

Sept 4 (Reuters) - EUROFINS SCIENTIFIC SE ::EUROFINS EXPANDS ITS LEADING GLOBAL COSMETIC TESTING FOOTPRINT WITH THE ACQUISITION OF CLINICAL RESEARCH LABORATORIES IN NORTH AMERICA.ANNOUNCES THAT IT HAS SUCCESSFULLY CLOSED THE ACQUISITION OF CLINICAL RESEARCH LABORATORIES LLC (“CRL”).  Full Article

Eurofins To Expand New Materials, Engineering Science Verticals With Acquisition Of Nanolab Technologies
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - EUROFINS SCIENTIFIC SE ::EUROFINS TO EXPAND NEW MATERIALS AND ENGINEERING SCIENCE VERTICALS WITH THE ACQUISITION OF NANOLAB TECHNOLOGIES, CEMENTING PRESENCE IN HIGH-TECH INDUSTRIES.TRANSACTION SHOULD BE IMMEDIATELY MARGIN-ACCRETIVE FOR EUROFINS AFTER CLOSING.DEAL IS EXPECTED TO CLOSE IN THE THIRD QUARTER OF 2018.  Full Article

Eurofins Acquires Of Ecosur
Friday, 27 Jul 2018 

July 27 (Reuters) - Eurofins Scientific SE ::EUROFINS BECOMES THE MARKET LEADER IN FOOD TESTING SERVICES IN SPAIN WITH THE ACQUISITION OF ECOSUR.IT HAS SUCCESSFULLY CLOSED ACQUISITION OF LABORATORIOS ECOSUR S.A..  Full Article

Eurofins Announces The Acquisition Of Laboratoire De Bromatologie De L’Ouest
Tuesday, 3 Jul 2018 

July 3 (Reuters) - EUROFINS SCIENTIFIC SE ::EUROFINS ANNOUNCES THE ACQUISITION OF LABORATOIRE DE BROMATOLOGIE DE L’OUEST (LBO) EXTENDING ITS NETWORK OF FOOD TESTING LABORATORIES IN FRANCE.  Full Article

Eurofins Raises Its Revenues Objectives For 2018
Tuesday, 26 Jun 2018 

June 26 (Reuters) - EUROFINS SCIENTIFIC SE ::EUROFINS RAISES ITS REVENUES OBJECTIVES FOR 2018 TO EUR 3.8BN (4BN PRO-FORMA), TO 4.3BN FOR 2019 AND TO 4.7BN FOR 2020*.IN 2019 CONSOLIDATED AT MIDYEAR, EUROFINS SHOULD BE ABLE TO REPORT REVENUES* IN EXCESS OF EUR 4.3BN.FOR 2020, EUROFINS IS SETTING AN OBJECTIVE TO REACH REVENUES* IN EXCESS OF EUR 4.7BN IN 2020.ACQUISITIONS SIGNED SO FAR IN 2018 SHOULD HAVE IMPACT ON BOTH 2018 AND 2019 CONSOLIDATED EBITDA MARGIN.ACQUISITIONS SIGNED SO FAR IN 2018, LIKE THOSE OF 2017, SHOULD HAVE AN ACCRETIVE IMPACT ON BOTH 2018 AND 2019 CONSOLIDATED EBITDA MARGIN.ADJUSTED EBITDA MARGIN SHOULD CONTINUE TO IMPROVE IN 2018 AND MORE SO IN 2019 AND 2020..CONFIRMS ITS 20% ADJUSTED EBITDA MARGIN OBJECTIVE FOR 2020..SHOULD NOT REQUIRE ADDITIONAL EQUITY.NET DEBT TO PRO-FORMA ADJUSTED EBITDA LEVERAGE** SHOULD REMAIN LARGELY WITHIN ITS COVENANT.  Full Article

Eurofins: U.S. Antitrust Clearance For Covance Food Solutions Acquisition
Thursday, 21 Jun 2018 

June 21 (Reuters) - EUROFINS SCIENTIFIC SE ::EUROFINS ANNOUNCES U.S. ANTITRUST CLEARANCE FOR THE ACQUISITION OF COVANCE FOOD SOLUTIONS.EXPIRATION OF WAITING PERIOD UNDER HART-SCOTT-RODINO ACT SATISFIES ONE OF CONDITIONS NECESSARY FOR CONSUMMATION OF ACQUISITION.ACQUISITION IS EXPECTED TO CLOSE IN Q3 OF 2018..ACQUISITION ENHANCES EUROFINS POSITION AS LEADER IN FOOD TESTING INDUSTRY IN THE U.S.  Full Article

Eurofins Buys Two Subsidiaries Of The VTT Group In Finland
Friday, 1 Jun 2018 

June 1 (Reuters) - EUROFINS SCIENTIFIC SE ::EUROFINS REINFORCES ITS MARKET LEADERSHIP IN TESTING, INSPECTION AND CERTIFICATION WITH THE ACQUISITION OF TWO SUBSIDIARIES OF THE VTT GROUP IN FINLAND.  Full Article

Eurofins Scientific Expands Biopharmaceutical Products Testing Footprint With Outsourcing Agreement With Astellas In Japan
Tuesday, 22 May 2018 

May 22 (Reuters) - EUROFINS SCIENTIFIC SE ::EXPANDS ITS BIOPHARMACEUTICAL PRODUCTS TESTING FOOTPRINT WITH AN OUTSOURCING AGREEMENT WITH ASTELLAS IN JAPAN.  Full Article

UPDATE 1-Eurofins Scientific raises outlook after acquisitions, Q3 growth

Oct 23 Luxembourg-based food and biopharma product testing firm Eurofins Scientific raised its earnings expectations for 2019 and 2020 for the second time this year on Tuesday following acquisitions and a strong third quarter.